Covidien Buys Barxx Med.

Posted by
|

This post is excerpted from a Covidien press release published on November 21st 2011, via Business Wire

“Covidien, a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett’s esophagus syndrome using bipolar radiofrequency (RF) ablation devices.

Covidien will acquire all of the outstanding capital stock of BÂRRX, a private company, for approximately $325 million, with future earn out payments possible based on achievement of specific milestones. The transaction, subject to customary closing conditions, including receipt of certain regulatory approvals, is expected to be completed by January 31, 2012.” …

Read the full press release from Covidien here

Add a comment

You must be logged in to comment.

Subscribe